Abeona Therapeutics (ABEO) Return on Sales (2016 - 2025)
Historic Return on Sales for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to 86.99%.
- Abeona Therapeutics' Return on Sales changed N/A to 86.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 86.99%, marking a year-over-year change of. This contributed to the annual value of 13.59% for FY2023, which is 229400.0% up from last year.
- Latest data reveals that Abeona Therapeutics reported Return on Sales of 86.99% as of Q3 2025.
- Abeona Therapeutics' Return on Sales' 5-year high stood at 972.27% during Q4 2021, with a 5-year trough of 192.85% in Q4 2022.
- In the last 5 years, Abeona Therapeutics' Return on Sales had a median value of 8.18% in 2022 and averaged 64.29%.
- Per our database at Business Quant, Abeona Therapeutics' Return on Sales soared by 9775500bps in 2021 and then tumbled by -11651200bps in 2022.
- Quarter analysis of 5 years shows Abeona Therapeutics' Return on Sales stood at 972.27% in 2021, then crashed by -120bps to 192.85% in 2022, then surged by 93bps to 13.59% in 2023, then fell by -7bps to 14.48% in 2024, then soared by 701bps to 86.99% in 2025.
- Its Return on Sales stands at 86.99% for Q3 2025, versus 272.08% for Q2 2025 and 14.48% for Q1 2024.